Further investigation revealed that inhibition of ADRB2 impedes lung fibrosis by reducing TGF-β/SMAD signaling activity through the acceleration of phos-SMAD2/3 proteasome degradation. This evidence concerns the gene TGFB1 and pulmonary fibrosis.